Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.45 USD | +1.32% | -16.67% | +3.71% |
Financials (USD)
Sales 2024 * | 5.83M | Sales 2025 * | - | Capitalization | 377M |
---|---|---|---|---|---|
Net income 2024 * | -100M | Net income 2025 * | -73M | EV / Sales 2024 * | 18.8 x |
Net cash position 2024 * | 267M | Net cash position 2025 * | 377M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.05
x | P/E ratio 2025 * |
-3.49
x | Employees | 38 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.27% |
Latest transcript on Cartesian Therapeutics, Inc.
1 day | +1.32% | ||
1 week | -16.67% | ||
Current month | -2.81% | ||
1 month | +10.62% | ||
3 months | +0.48% | ||
Current year | +3.71% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 21.45 | +1.32% | 23,444 |
24-05-10 | 21.17 | -3.16% | 54,832 |
24-05-09 | 21.86 | -5.98% | 44,221 |
24-05-08 | 23.25 | +0.19% | 41,193 |
24-05-07 | 23.2 | -9.85% | 82,896 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.71% | 377M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- RNAC Stock